Escalon Medical Corp. (OTCMKTS:ESMC) Short Interest Update

Escalon Medical Corp. (OTCMKTS:ESMC) was the target of a significant increase in short interest in the month of May. As of May 15th, there was short interest totaling 171,227 shares, an increase of 1,141,413.3% from the April 30th total of 15 shares. Currently, 2.4% of the company’s stock are short sold. Based on an average daily volume of 83,991 shares, the days-to-cover ratio is presently 2.0 days.

Escalon Medical Price Performance

ESMC stock opened at $0.21 on Friday. The firm has a 50 day moving average price of $0.19 and a 200-day moving average price of $0.18. Escalon Medical has a 52-week low of $0.10 and a 52-week high of $0.46. The firm has a market capitalization of $1.56 million, a price-to-earnings ratio of 1.91 and a beta of 0.11. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.94 and a current ratio of 2.59.

Escalon Medical (OTCMKTS:ESMC) last posted its quarterly earnings results on Friday, May 15th. The medical equipment provider reported $0.16 earnings per share for the quarter. Escalon Medical had a negative return on equity of 21.42% and a net margin of 16.17%.The company had revenue of $2.61 million for the quarter.

Escalon Medical Company Profile

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.